Cancer (n = 307) | Non-cancer (n = 100) | P-value | |
---|---|---|---|
Sex, n (%) | 0.48 | ||
Male | 138 (44.9) | 49 (49) | |
Female | 169 (55.1) | 51 (51) | |
Age (Mean ± SD) | 60.6 ± 14.9 | 70.4 ± 18.3 | < 0.001 |
Age group, n (%) | < 0.001 | ||
< 45 | 41 (13.4) | 10 (10) | |
45–54 | 56 (18.2) | 13 (13) | |
55–64 | 84 (27.4) | 15 (15) | |
65–74 | 71 (23.1) | 10 (10) | |
75–84 | 42 (13.7) | 25 (25) | |
≥ 85 | 13 (4.2) | 27 (27) | |
Co-morbidities, n (%) | |||
Hypertension | 96 (31.3) | 52 (52) | < 0.001 |
Diabetes mellitus | 50 (16.3) | 23 (23) | 0.13 |
Dyslipidemia | 62 (20.2) | 34 (34) | 0.01 |
Chronic kidney disease stage II-IV | 69 (22.5) | 22 (22) | 0.92 |
Psychiatric disorders | 22 (7.2) | 11 (11) | 0.22 |
Number of co-morbidities, median (percentile 25, percentile 75) | 1 (0, 2) | 1 (0, 3) | < 0.001* |
Number of co-morbidities, n (%) | 0.001 | ||
none | 146 (47.5) | 26 (26) | |
1 | 73 (23.8) | 27 (27) | |
2 | 45 (14.7) | 20 (20) | |
≥ 3 | 43 (14.0) | 27 (27) | |
Cancer types, n (%) | |||
Gastrointestinal | 122 (39.7) | ||
Lung | 54 (17.6) | ||
Genitourinary | 51 (16.6) | ||
Breast | 25 (8.1) | ||
Hematologic | 21 (6.8) | ||
Bone and soft tissue | 8 (2.6) | ||
Others | 28 (8.5) | ||
Non-cancer diagnoses, n (%) | |||
Neurological disorders | 38 (38) | ||
Heart disease | 13 (13) | ||
End-stage renal disease | 12 (12) | ||
Others | 37 (37) |